Ensign Peak Advisors, Inc
Position in OLMA — Olema Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in OLMA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,443,019
+$1,333,130 QoQ
Shares Held
96,782
+413.5% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in OLMA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,443,019 | 96,782 | Shares | Sole | 2026-05-13 | |
| 2024-12-31 | $109,889 | 18,849 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $225,057 | 18,849 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $160,666 | 14,849 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $158,468 | 13,999 | Shares | Sole | 2024-05-14 | |
| 2021-06-30 | $274,204 | 9,800 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $218,988 | 6,600 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||